News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

How Bay Area's Invitae's Sales Could Double in 2017



3/20/2017 6:28:21 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Wall Street loves companies that consistently post double- or triple-digit sales growth. These stocks usually excel in bull markets, but they can also be crushed when their growth starts slowing down or they're unable to squeeze out meaningful bottom line growth.

Let's take a closer look at three stocks that could double their revenues this year -- LogMeIn, Snap, and Invitae -- and the risks that their high-growth business models could face.

Invitae

Invitae uses software tools to process DNA samples, analyze information about genetic conditions, and generate test reports for clinicians. Its customizable tests screen for multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other conditions.

Read at Motley Fool


comments powered by Disqus
Invitae
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES